In the last 20 years, with the use of computed tomography (CT) angiography, the number of patients diagnosed with pulmonary thromboembolism (PTE) has increased. At the same time, data show that pulmonary embolism mortality has also reduced in this duration.
INTRODUCTION
Pulmonary thromboembolism (PTE) is an important public health concern that causes mortality and morbidity. Its non-specific symptoms and findings lead to difficulties in confirming its diagnosis. However, with the use of computed tomography (CT) angiography in recent years, an important step has been taken in the diagnosis of PTE. Moreover, improvements, such as the development of new anticoagulants and mechanical interventions, have occurred in the treatment of PTE. In parallel with all these improvements, data on the incidence and outcomes of the disease seems to be restricted.
Data on age, sex, diagnosis dates, diagnostic methods, presence of cancer, hemodynamic states, first-line and maintenance treatments, hospitalization length, and inhospital mortality were recorded. The primary endpoint was considered to be in-hospital mortality and hospitalization length.
A systolic arterial blood pressure of <90 mmHg at admission was taken into consideration for the diagnosis of massive PTE. However, PTE was defined as massive only in patients requiring a mechanical ventilator during hospitalization and developing hypotension in the follow-up period.
Statistical Analysis
The Kolmogorov-Smirnov test was used for the parametric and non-parametric distribution of data. Data were presented as mean±SD and median±interquartilee range. A pvalue of <0.05 was accepted to be significant. Data were recorded on Statistical Package for the Social Sciences (version 13.01, serial number 9069728, SPSS Inc., Chicago) and were analyzed.
RESULTS
A total of 1409 patients were scanned using ICD's (I26.0 and I26.9) between 2001 and 2013. After a complete analysis of patient's records, it was observed that final diagnosis was PTE in 1185 (84.1%). The number of patients diagnosed with PTE gradually increased between 2001 and 2013. The patients diagnosed with PTE in 2009 constituted 13.7% of the total number of patients diagnosed ( Figure 1) (Figure 2 ). While the rate of vena cava filter use was 1.1% in 2007, it was 4.6% in 2013.
In our study, the rate of standard heparin (SH) use in the acute phase of PTE in all patients was 45.5% the rate of low molecular weight heparin (LMWH) use was 40.2%, and the rate of thrombolytic use was 5%. While the rate of SH use was 72.1% in 2013, it decreased to 17.1% in 2013 (p<0.001, Table 1 ).
The general mortality rate was 13% and the in-hospital mortality rate fluctuated between 9.4% and 18.8% over the years from 2001 to 2013. No significant difference was found among the years in terms of the mortality rate (p<0.05) ( Figure 3 ). While mortality rate was 12.9% in male patients, it was 13.1% in female patients. There was a statistically significant difference between both sexes with regard to the mortality rate.
The rate of thrombolytic use increased in patients with massive PTE over the years. While the rate of massive PTE pa- Mortality rate tients was 8.5% in 2006, the rate of thrombolytic use was 5.8%. In 2013, the rate of patients diagnosed with massive PTE was 2.6%, but the rate of thrombolytic use was 6% (p=0.017). Thus, it was observed that thrombolytic use increased in non-massive patients over the years.
DISCUSSION
In this study, it was found that the number of patients diagnosed with PTE gradually increased over time but that the mortality rate did not change. Moreover, an increase in the rate LMWH use was observed both in the acute stage and the maintenance period. While the mean hospitalization length was 13 days in 2001, it was 7 days in 2013. Over the years, the hospitalization length was observed to decrease.
The clinical course of PTE can vary from asymptomatic cases to sudden deaths. Data obtained till date show that the number of patients diagnosed with PTE has increased. Similarly, the number of PTE patients has apparently increased according to our clinical observations. In our study, it was found that the number of patients diagnosed with PTE relatively decreased in 2011. The most important cause for this decrease is that technical capacities and clinical experiences in diagnosing and treating PTE have increased in other hospitals of Eastern Black Sea Region.
The rate of mortality due to PTE has generally decreased over the years. In particular, the detection of clinically insignificant patients can contribute to a decreased mortality rate. In a study conducted in USA, the mortality rate was reported to decrease from 7.1% to 3.2% over 20 years [1] . In another study conducted in Australia, it was revealed that the mortality rate decreased over years but that PTE was still an important cause of mortality and morbidity in females and the elderly population [4] . In our study, the overall mortality rate was around 13%, and no change was observed in the mortality rate over the years. The mortality rate was found to be 13% in our two prospective studies between 2008 and 2009 and between 2012 and 2014 [5, 6] . However, while the PTErelated mortality rate was 5.6% in our first study, it was 4.4% in the other one. Based on many factors that can influence the mortality rate, such as accompanying co morbid disorders, the application of clinically more severe patients to our hospital because of the provision of tertiary health care, and not performing autopsy for finding the real cause of death, the mortality rate was not observed to have changed over the years in our current study.
The use of CT for the diagnosis of PTE increased for five times in between 2001 and 2009 [7] . In another study, while no change was found in the incidence of PTE in the years before the use of CT pulmonary angiography, the incidence increased to 81% with the use of CT [8] . Further, in our study, a dramatic increase was observed with the use of CT between 2001 to 2013, compared to the first years. The increased rate of PTE diagnoses may reveal another problem. Complications developing in association with anticoagulant therapy lead to mortality and morbidity. The clinically significant complication of bleeding was reported to have developed at the rate of 12% during anticoagulant use for 3-6 months [9] . An increased number of patients are exposed to radiation; therefore, the effects of radiation damage will be observed in the long term.
In addition, changes in the selection of anticoagulants were also observed over the years. In the present study, the rate of SH use decreased from 72% to 17% (an approximately decrease of 4.5 times). On the contrary, the rate of LMWH use increased from 25% to 82%. In the study by Jimenez et al. on 23858 patients between 2001 and 2013, while the rate It has been observed seen that the hospitalization length and high hospital costs has shortened over time due to increased experience of physicians and increased use of LMWHs. In a study conducted in USA, the median hospitalization length was reported to have decreased from 8 days to 4 days [1] . In another study, the median hospitalization length decreased from 13.6 days to 9.3 days within a 13-year period [10] . In our study, the hospitalization length decreased from 13 days to 7 days. In clinical practice, it is seen that accompanying co morbid conditions are one of the most important factors affecting long hospitalization lengths. Another factor that may decrease the hospitalization length is the use of LMWH instead of warfarin because warfarin dosing in maintenance treatment can sometimes take a longer time due to its changing metabolism each other.
This study has some limitations. Firstly, it cannot be suggested that the study included all patients diagnosed with PTE because it was a retrospective, single-center study. Moreover, we do not know the exact number of PTE patients who were coded using other ICDs (dyspnea, respiratory failure, hemoptysis, chest pain, respiratory arrest, etc.) except than I26.0 and I26.9. In addition, we have no data on the treatments that patients received between the 2001 and 2005. Accompanying morbidities of the patients could not be documented. Hence, all-cause mortality was presented. It can be suggested that changes in the morbidity rate can change the mortality rate over the years.
In conclusion, despite the increased number of patients diagnosed with PTE, it was observed that the mortality rate did not change over the years.
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